Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT00508443
What this trial is testing

Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)

Who this might be right for
Spinal Neoplasms
M.D. Anderson Cancer Center 150
Not applicableNot Yet RecruitingNCT07819474
What this trial is testing

Optimizing Tumor-Infiltrating Lymphocyte (TIL) Harvest Site and Patient Selection With CD8-PET Imaging in Patients With

Who this might be right for
Tumor Infiltrating LymphocyteCD8-PETAdvanced Melanoma
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT02821182
What this trial is testing

A Phase II Trial of Stereotactic Body Radiotherapy With Concurrent Anti-PD1 Treatment in Metastatic Melanoma.

Who this might be right for
Melanoma
University Hospital, Ghent 20
Not applicableStudy completedNCT04201223
What this trial is testing

Family Lifestyles, Actions, and Risk Education Intervention: Version 2

Who this might be right for
MelanomaChild
University of Utah 752
Early research (Phase 1)Study completedNCT03894618
What this trial is testing

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckMelanomaNon Small Cell Lung Cancer+10 more
Shattuck Labs, Inc. 49
Testing effectiveness (Phase 2)Study completedNCT00818480
What this trial is testing

An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155

Who this might be right for
Prostate CancerMelanomaNon-Hodgkin's Lymphoma
Astellas Pharma Inc 10
Not applicableStudy completedNCT00889980
What this trial is testing

Melanoma Molecular Profiling Analysis

Who this might be right for
Melanoma
University of Pittsburgh 237
Testing effectiveness (Phase 2)Looking for participantsNCT07223424
What this trial is testing

Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

Who this might be right for
Renal Cell CarcinomaNon Small Cell Lung CancerMelanoma+9 more
Diwakar Davar 880
Early research (Phase 1)Ended earlyNCT04990479
What this trial is testing

Nous-PEV: a Novel Immunotherapy for Lung Cancer and Melanoma

Who this might be right for
Melanoma (Skin)Non-Small-Cell Lung Carcinoma
Nouscom SRL 7
Testing effectiveness (Phase 2)Study completedNCT00509288
What this trial is testing

Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 F5 TCR-Gene-Engineered Lymphocytes

Who this might be right for
MelanomaSkin Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)WithdrawnNCT04007588
What this trial is testing

A Phase II Trial of Neoadjuvant Treatment With PD-1 Inhibition (Nivolumab) With or Without IDO Inhibition (BMS-986205) and With or Without CTLA-4 Inhibition (Ipilimumab) in Resectable Stage III or IV Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00738361
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery

Who this might be right for
Intraocular Melanoma
Ohio State University Comprehensive Cancer Center 4
Large-scale testing (Phase 3)Ended earlyNCT02288897
What this trial is testing

PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma

Who this might be right for
Cutaneous Melanoma
Provectus Biopharmaceuticals, Inc. 20
Not applicableActive Not RecruitingNCT05736523
What this trial is testing

Improving Early Detection of Melanoma Recurrence With Circulating Tumor DNA (ctDNA)

Who this might be right for
Melanoma
University of Utah 28
Not applicableStudy completedNCT03174574
What this trial is testing

Two Cancers, One Gene. Why Some People in Families Develop Melanoma or Pancreas Cancer, While Still Others Never Develop Cancer.

Who this might be right for
Pancreas CancerMelanoma
Mayo Clinic 3
Early research (Phase 1)Study completedNCT01242618
What this trial is testing

Tissue Engineered Nasal Cartilage for Reconstruction of the Alar Lobule

Who this might be right for
Skin Carcinoma
University Hospital, Basel, Switzerland 5
Not applicableStudy completedNCT00723710
What this trial is testing

Effect of Proactive Management of Side Effects on Treatment Compliance in Malignant Melanoma Patients on High-dose Intron A Therapy (Study P04600)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 299
Early research (Phase 1)Study completedNCT00790010
What this trial is testing

Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma

Who this might be right for
Melanoma
Dana-Farber Cancer Institute 46
Not applicableActive Not RecruitingNCT06146920
What this trial is testing

Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation

Who this might be right for
MelanomaNon-small Cell Lung Cancer
Massachusetts General Hospital 39
Testing effectiveness (Phase 2)Study completedNCT00096382
What this trial is testing

Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Institutes of Health Clinical Center (CC) 34
Next Page